Comparison of two different neoadjuvant chemoradiatiotherapy regimens for locally advanced rectal cancer: Results of a phase II, multicenter, randomized trial.

被引：0
|
作者：
Zhu, Ji
Guan, Yun
Yan, Senxiang
Xu, Ye
Li, Xinxiang
Cai, Sanjun
Zhang, Zhen
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3614
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3614
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [12] Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
    Velenik, Vaneja
    Oblak, Irena
    Anderluh, Franc
    RADIATION ONCOLOGY, 2010, 5
  • [13] Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
    Vaneja Velenik
    Irena Oblak
    Franc Anderluh
    Radiation Oncology, 5
  • [14] A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer
    Patil, Prachi S.
    Saklani, Avanish
    Kumar, Naveena A. N.
    De'Souza, Ashwin
    Krishnatry, Rahul
    Khanvilkar, Snehal
    Kazi, Mufaddal
    Engineer, Reena
    Ostwal, Vikas
    Ramaswamy, Anant
    Bal, Munita
    Ranganathan, Priya
    Gupta, Ekta
    Galande, Sanjeev
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [15] Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial
    De Felice, F.
    D'Ambrosio, G.
    Iafrate, F.
    Gelibter, A.
    Magliocca, F. M.
    Musio, D.
    Caponetto, S.
    Casella, G.
    Clementi, I
    Picchetto, A.
    Sirgiovani, G.
    Parisi, M.
    Orciuoli, C.
    Torrese, G.
    De Toma, G.
    Tombolini, V
    Cortesi, E.
    CLINICAL ONCOLOGY, 2021, 33 (12) : 788 - 794
  • [16] Perioperative chemotherapy using FOLFOX with panitumumab for locally advanced rectal cancer: Phase II trial.
    Ota, Mitsuyoshi
    Watanabe, Jun
    Ishibe, Atsushi
    Suwa, Hirokazu
    Momiyama, Masashi
    Ichikawa, Yasushi
    Kunisaki, Chikara
    Endo, Itaru
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [17] Phase II Trial of Neoadjuvant Chemotherapy with XELOX plus Bevacizumab for Locally Advanced Rectal Cancer
    Uehara, Keisuke
    Ishiguro, Seiji
    Sakamoto, Eiji
    Maeda, Atsuyuki
    Inoue, Masaya
    Tojima, Yuichiro
    Kobayashi, Satoshi
    Omiya, Naoki
    Ishizuka, Naoki
    Nakao, Akimasa
    Goto, Hidemi
    Nagino, Masato
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1041 - 1044
  • [18] Tailored treatment strategy for locally advanced rectal carcinoma: Five-year results of the French phase II, randomized, multicenter GRECCAR4 trial.
    Rouanet, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [19] Results of a prospective phase II study of total neoadjuvant therapy for locally advanced rectal cancer
    Ma, Huiying
    Tang, Yuan
    Zhang, Wenjue
    Zhou, Haitao
    Liu, Zheng
    Zhang, Haizeng
    Cai, Yong
    Li, Yongheng
    Wei, Lichun
    Liu, Shixin
    Wang, Wenling
    Song, Yongwen
    Chen, Bo
    Lu, Ningning
    Qi, Shunan
    Liu, Yueping
    Wang, Shulian
    Wang, Xishan
    Li, Yexiong
    Jin, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 147 - 147
  • [20] A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.
    Goto, Saori
    Hasegawa, Suguru
    Matsumoto, Takuya
    Hida, Koya
    Kawamura, Junichiro
    Yamanokuchi, Satoshi
    Yamaguchi, Takashi
    Matsusue, Ryo
    Kadokawa, Yoshio
    Kato, Shigeru
    Manaka, Dai
    Nishitai, Ryuta
    Nomura, Akinari
    Kanazawa, Akiyoshi
    Kawada, Kenji
    Kyogoku, Takahisa
    Sakai, Yoshiharu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345